Chaonan Liu , Xunbei Huang , Liqin Ling, Qiang Meng, Juan Liao, Jing Zhou
{"title":"Implementation and validation of an intelligent auto-verification system in a coagulation testing automatic line","authors":"Chaonan Liu , Xunbei Huang , Liqin Ling, Qiang Meng, Juan Liao, Jing Zhou","doi":"10.1016/j.clinbiochem.2025.110969","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the implementation and optimization of a fully automated coagulation testing system integrating dual-coagulation-autoline and auto-verification protocols in a high-throughput laboratory, aiming to enhance operational efficiency, standardization, and clinical utility.</div></div><div><h3>Methods</h3><div>A dual-coagulation-autoline system was deployed, each line equipped with four automated coagulation analyzers. Pre-implementation quality assessments evaluated centrifuge performance, open/closed-cap sampling, robotic arm effects, and sample stability. Auto-verification rules were optimized using several guidelines and validated with 18,373 samples. Key metrics included pass rate, sensitivity, specificity, and turnaround time (TAT).</div></div><div><h3>Results</h3><div>All centrifuged specimens met platelet-poor plasma criteria (platelet count <10 × 10<sup>9</sup>/L). No significant differences (P > 0.05) were observed between open/closed-cap sampling, robotic arm handling, or room-temperature storage (≤4h). The dual-coagulation-autoline system reduced outpatient and inpatient TAT by 16.78 % (from 49.77 min to 41.42 min) and 33.06 % (from 110.3 min to 73.83 min), respectively, while sample volume increased by 7.9 % (from 74,902 to 80,869). Optimized auto-verification rules achieved a 62.48 % pass rate (11,479/18,373), 100 % sensitivity, 93.50 % specificity, and 0 % false negatives, outperforming initial benchmarks. Auto-verification reduced outpatient and inpatient TAT by 8.29 % (from 41.42 min to 38.25 min) and 16.21 % (from 73.83 min to 63.53 min), respectively, while sample volume increased by 2.8 % (from 80,869 to 83,126).</div></div><div><h3>Discussion</h3><div>The integration of dual-coagulation-autoline and refined auto-verification significantly improved TAT, reduced manual errors, and standardized workflows in a high-volume setting. Personalized system optimization, including dynamic testing allocation and real-time tracking, enhanced clinical efficiency. The validated auto-verification framework demonstrated robust generalizability for large-scale laboratories. The successful application and personalized setting of our laboratory can provide experience for other laboratories.</div></div>","PeriodicalId":10172,"journal":{"name":"Clinical biochemistry","volume":"139 ","pages":"Article 110969"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical biochemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009912025000980","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the implementation and optimization of a fully automated coagulation testing system integrating dual-coagulation-autoline and auto-verification protocols in a high-throughput laboratory, aiming to enhance operational efficiency, standardization, and clinical utility.
Methods
A dual-coagulation-autoline system was deployed, each line equipped with four automated coagulation analyzers. Pre-implementation quality assessments evaluated centrifuge performance, open/closed-cap sampling, robotic arm effects, and sample stability. Auto-verification rules were optimized using several guidelines and validated with 18,373 samples. Key metrics included pass rate, sensitivity, specificity, and turnaround time (TAT).
Results
All centrifuged specimens met platelet-poor plasma criteria (platelet count <10 × 109/L). No significant differences (P > 0.05) were observed between open/closed-cap sampling, robotic arm handling, or room-temperature storage (≤4h). The dual-coagulation-autoline system reduced outpatient and inpatient TAT by 16.78 % (from 49.77 min to 41.42 min) and 33.06 % (from 110.3 min to 73.83 min), respectively, while sample volume increased by 7.9 % (from 74,902 to 80,869). Optimized auto-verification rules achieved a 62.48 % pass rate (11,479/18,373), 100 % sensitivity, 93.50 % specificity, and 0 % false negatives, outperforming initial benchmarks. Auto-verification reduced outpatient and inpatient TAT by 8.29 % (from 41.42 min to 38.25 min) and 16.21 % (from 73.83 min to 63.53 min), respectively, while sample volume increased by 2.8 % (from 80,869 to 83,126).
Discussion
The integration of dual-coagulation-autoline and refined auto-verification significantly improved TAT, reduced manual errors, and standardized workflows in a high-volume setting. Personalized system optimization, including dynamic testing allocation and real-time tracking, enhanced clinical efficiency. The validated auto-verification framework demonstrated robust generalizability for large-scale laboratories. The successful application and personalized setting of our laboratory can provide experience for other laboratories.
期刊介绍:
Clinical Biochemistry publishes articles relating to clinical chemistry, molecular biology and genetics, therapeutic drug monitoring and toxicology, laboratory immunology and laboratory medicine in general, with the focus on analytical and clinical investigation of laboratory tests in humans used for diagnosis, prognosis, treatment and therapy, and monitoring of disease.